Tweener

Polaris Quantum Biotech

Invested in 
2024 Q4
Tweener

Polaris Quantum Biotech

Invested in 
2024 Q4
 
Back

Polaris Quantum Biotech has developed the first drug discovery platform using quantum computing technology, making the process ten times faster than traditional methods. Their platform combines quantum computing, artificial intelligence, and machine learning to scan billions of molecules efficiently, compressing the lead time for preclinical drug candidates from 5 years to 4 months.

Sector: 
QuantumTech
Share this company